20. Adrenoleukodystrophy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 61 / Drugs : 90 - (DrugBank : 31) / Drug target genes : 23 - Drug target pathways : 126
| Previous names | - | ||
|---|---|---|---|
| Other names | ALD; | ||
| Disease group | Metabolic diseases | ||
| Related info (in Japanese) | - | ||
| Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-7-104. Adrenoleukodystrophy | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 20-1. | Childhood cerebral adrenoleukodystrophy;Childhood cerebral ALD;CCALD; | 8-7-104. Adrenoleukodystrophy | |
| 20-2. | Adolescent cerebral adrenomyeloneuropathy;AdolCALD; | 8-7-104. Adrenoleukodystrophy | |
| 20-3. | Adrenomyeloneuropathy;AMN; | 8-7-104. Adrenoleukodystrophy | |
| 20-4. | Adult cerebral adrenoleukodystrophy;ACALD; | 8-7-104. Adrenoleukodystrophy | |
| 20-5. | Cerebellum-brain stem type adrenoleukodystrophy; | 8-7-104. Adrenoleukodystrophy | |
| 20-6. | Addison-only adrenoleukodystrophy;AO ALD; | 8-7-104. Adrenoleukodystrophy | |
| 20-7. | Adrenoleukodystrophy (Female onset); | 8-7-104. Adrenoleukodystrophy | |